Pharmacology, Toxicology and Pharmaceutical Science
Antifungal Agent
100%
Itraconazole
98%
Pentoxifylline
84%
Nanoparticle
84%
Chemopreventive Agents
56%
Infection
55%
High Performance Liquid Chromatography
47%
Genistein
42%
Mouse
42%
Pharmacokinetic Modeling
42%
Voriconazole
42%
Polyglactin
42%
Histoplasmosis
42%
South American Blastomycosis
42%
Lung Fibrosis
42%
Colon Adenocarcinoma
42%
Azoxymethane
42%
Colon Carcinogenesis
42%
Aberrant Crypt Foci
42%
Carboxamide
42%
Anticarcinogen
42%
Allyl
42%
Isoniazid
42%
Cuprous Ion
42%
Hydrazone Derivative
42%
Fibrosis
33%
Disease
33%
S-Allyl Cysteine
28%
Matrilysin
28%
Antifungal Therapy
23%
Hydroxyl Group
21%
Styrene Derivative
21%
Resveratrol
21%
Colon Carcinoma
21%
Oxidizing Agent
21%
Posaconazole
21%
Lead Compound
21%
Paracoccidioides
16%
Lung Lesion
14%
Caspase
14%
Molecular Docking Simulations
14%
Caspase 8
14%
Hydrogen
14%
Benzotriazole Derivative
14%
Colon Cancer
14%
Membrane Damage
14%
Primary Tumor
14%
Interleukin 6
14%
Cytotoxicity
14%
Caspase 3
14%
Immunology and Microbiology
High Performance Liquid Chromatography
84%
Paracoccidioides brasiliensis
65%
Conidium
63%
Blood Level
56%
Liquid Chromatography
42%
Glycolic Acid
42%
Soft Tissue
42%
Inflammation Response
42%
Pentoxifylline
42%
Cryptococcus gattii
42%
Filobasidiella
42%
Inflammatory Cytokine
42%
Yeast Cell
42%
Gene Expression Profiling
42%
Silver Staining
42%
Staining
42%
Antifungal Activity
42%
Cell Line
42%
Cell Cycle G1 Phase
42%
Selectivity Index
42%
Cancer Cell
42%
Mouse
35%
Polyclonal Antibody
31%
Mobile Phase Composition
28%
Retention Time
28%
Interleukin 13
25%
Drug Solubility
21%
Immunocompetent Cell
21%
Colony Forming Unit S
21%
Drug Degradation
21%
Ajellomyces capsulatus
21%
Capillary
21%
Hemostasis
21%
Tissue Water
21%
Body Fluid
21%
Tumor Necrosis Factor
21%
Interleukin-1
21%
Cytokine
21%
Artificial Intelligence
21%
ELISA
21%
SW480 Cell Line
21%
Cancer Cell Line
21%
Antiproliferative Activity
21%
Colon Cell
21%
SW620 Cell Line
21%
Cell Viability
21%
Cell Membrane
21%
Propidium Iodide
21%
Cell Cycle Arrest
21%
Low Drug Dose
21%